OnabotulinumtoxinA Reduces Disability in Treatment-naive Adult Patients with Spasticity: Results from the ASPIRE Study
OnabotulinumtoxinA Treatment in Adults with Spasticity Reduces Caregiver Burden: Results from the ASPIRE Study
Orosomucoid (ORM) Is Associated with Decreased Daily Activity Level and Resting O2 Volume
Outcome in a Comatose Patient with Continuous Stay in the Acute Hospital Setting: A Case Report
AAPM&R Annual Assembly 2019
November 14-17, 2019. San Antonio, Texas.